Compare MRTN & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRTN | PSNL |
|---|---|---|
| Founded | 1946 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 1994 | 2019 |
| Metric | MRTN | PSNL |
|---|---|---|
| Price | $12.78 | $15.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 5 |
| Target Price | ★ $17.00 | $15.17 |
| AVG Volume (30 Days) | 782.7K | ★ 1.9M |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.88% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $1,131,455,000.00 | $69,648,000.00 |
| Revenue This Year | $1.27 | $21.10 |
| Revenue Next Year | $9.72 | $30.66 |
| P/E Ratio | $158.94 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.35 | $4.96 |
| 52 Week High | $18.48 | $18.89 |
| Indicator | MRTN | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 44.78 |
| Support Level | $12.71 | $13.68 |
| Resistance Level | $13.00 | $16.58 |
| Average True Range (ATR) | 0.27 | 0.38 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 23.57 | 17.43 |
Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.